Temerty Centre for Therapeutic Brain Intervention

Temerty Centre for Therapeutic Brain Intervention
Name	Temerty Centre for Therapeutic Brain Intervention
Established	2019
Type	Research institute
Location	Toronto, Ontario, Canada
Affiliations	University of Toronto, Toronto Western Hospital, University Health Network
Director	Mandy C. Smith

Temerty Centre for Therapeutic Brain Intervention is a clinical and research institute focused on neuromodulation, psychiatric neurosurgery, and translational neuroscience located in Toronto, Ontario. The Centre operates within a network of hospitals and universities and engages with a wide range of partners to develop treatments for major depressive disorder, obsessive–compulsive disorder, Parkinson's disease, and other neurological and psychiatric conditions. Its work intersects with clinical trials, device development, and health policy initiatives involving multiple teaching hospitals and research foundations.

History

The Centre was established following a major philanthropic gift to University of Toronto and University Health Network and emerged amid local initiatives tied to Toronto Western Hospital, Baycrest Health Sciences, McMaster University, and national partners such as Canadian Institutes of Health Research. Early leadership included clinicians and scientists associated with Sunnybrook Health Sciences Centre, St. Michael's Hospital (Toronto), and international collaborators from Massachusetts General Hospital, Johns Hopkins Hospital, Mayo Clinic, and Charité – Universitätsmedizin Berlin. Its founding paralleled developments in neuromodulation at institutions like Oxford University Hospitals NHS Foundation Trust, Karolinska Institutet, and University College London Hospitals NHS Foundation Trust. The Centre’s inception coincided with policy discussions in Ontario health ministries and funding initiatives from foundations tied to prominent donors and organizations including The Rockefeller Foundation, Bill & Melinda Gates Foundation, and national research councils.

Facilities and Research Infrastructure

The Centre is housed in facilities integrated with Toronto Western Hospital and associated laboratories at University of Toronto campuses, equipped for electrophysiology, neuroimaging, and device testing. Core infrastructure includes magnetoencephalography suites akin to those at McGill University Health Centre, functional magnetic resonance imaging compatible labs similar to Stanford University School of Medicine setups, and clean rooms for device assembly comparable to facilities at MIT. The Centre’s operating theaters support stereotactic procedures used at Cleveland Clinic, Mount Sinai Hospital (New York), and Hospital of the University of Pennsylvania. Biobanks and data cores follow standards used by Wellcome Trust–funded consortia and coordinate with registries such as ClinicalTrials.gov and networks like Global Alliance for Chronic Diseases. Engineering partnerships draw on practices from Siemens Healthineers, Medtronic, Boston Scientific, and startups spun out from Imperial College London and ETH Zurich.

Clinical Programs and Treatments

Clinical programs offer services in deep brain stimulation protocols pioneered at University of Cologne, transcranial magnetic stimulation approaches developed at National Institutes of Health, and investigational closed-loop neuromodulation influenced by trials at Case Western Reserve University and Vanderbilt University Medical Center. Treatment teams include specialists with backgrounds from McGill University, Columbia University Irving Medical Center, University of California, San Francisco, and Yale School of Medicine. The Centre runs multidisciplinary clinics modeled on programs at Karolinska University Hospital and Royal Melbourne Hospital, providing care pathways for patients referred from community hospitals such as North York General Hospital and Scarborough Health Network. Clinical governance aligns with regulatory frameworks used by Health Canada and practice guidelines from bodies like American Psychiatric Association and Royal College of Physicians and Surgeons of Canada.

Research Focus and Major Projects

Research spans mechanistic studies of circuit dysfunction informed by work at Duke University School of Medicine, longitudinal cohort studies echoing designs from Framingham Heart Study, and device innovation comparable to programs at University of Oxford and University of Pennsylvania Perelman School of Medicine. Major projects include randomized controlled trials of neuromodulation for treatment-resistant depression that align with methodologies from NIH-funded trials, adaptive stimulation paradigms based on algorithms developed with collaborators at Carnegie Mellon University and ETH Zurich, and translational programs linking genetic findings from consortia like Psychiatric Genomics Consortium with electrophysiological biomarkers identified at McLean Hospital. Subprojects engage computational neuroscience teams influenced by work at DeepMind, signal-processing groups from Google Brain, and neuroethics scholars connected to University of Oxford and Harvard University.

Collaborations and Funding

The Centre maintains partnerships with academic hospitals and industry, collaborating with Medtronic, Abbott Laboratories, and NeuroPace on device trials, and with university partners such as McMaster University, Queen's University, University of British Columbia, and Université de Montréal. Funding sources include philanthropic donors reminiscent of major gifts to University of Toronto, competitive awards from Canadian Institutes of Health Research, program grants from Brain Canada Foundation, and translational funds linked to agencies like Innovation, Science and Economic Development Canada and provincial research bodies. International research links extend to consortia involving European Union research frameworks, bilateral agreements with National Science Foundation (United States), and collaborative studies with groups at Imperial College London and École Polytechnique Fédérale de Lausanne.

Education, Training, and Outreach

Training programs support fellows in neurosurgery, psychiatry, and neuroscience with rotations influenced by curricula at University of Toronto Faculty of Medicine, Johns Hopkins University School of Medicine, and UCLA David Geffen School of Medicine. The Centre hosts workshops and symposia drawing speakers from Society for Neuroscience, World Psychiatric Association, International Neuromodulation Society, and conferences such as American Academy of Neurology annual meetings. Public engagement includes collaborations with patient advocacy organizations like Canadian Mental Health Association and educational outreach modeled after initiatives at Brain Canada and Wellcome Trust. The Centre contributes to policy dialogues involving provincial health authorities and national advisory panels connected to Health Canada and professional colleges.

Category:Neuroscience research institutes